台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    60.9
  • 漲跌
    ▲1.2
  • 漲幅
    +2.01%
  • 成交量
    158
  • 產業
    上櫃 生技醫療類股
  • 69人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
易威 (1799)籌碼相關-富邦-北港 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-北港 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.001060.5060.90-10604-1.65%
2025/01/1400.00161.0062.90-1621-0.16%
2025/01/13167.001167.0562.80-10627-1.59%
2025/01/10565.0000.0065.4056240.80%
2025/01/09261.5000.0061.2026170.32%
2024/12/31163.7000.0064.3016690.15%
2024/12/261969.9100.0066.60196922.74%
2024/12/25773.17275.3574.0056830.73%
2024/12/2000.00160.8060.40-1684-0.15%
2024/12/19665.5700.0062.7066950.86%
2024/12/0900.00462.2562.00-4646-0.62%
2024/11/27166.8000.0066.5016770.15%
2024/11/25171.000.372.0071.900.76810.10%
2024/11/220.174.7000.0073.000.16720.01%
2024/11/21267.30367.2068.00-1662-0.15%
2024/11/19367.8000.0067.4036670.45%
2024/11/150.269.10370.1066.00-2.8678-0.41%
2024/11/14369.0000.0069.0036700.45%
2024/11/13266.20264.4064.0006520.00%
2024/11/12263.4000.0070.0026320.32%
2024/11/1100.00270.1070.10-2606-0.33%
2024/11/0800.00278.0077.80-2603-0.33%
2024/10/2800.00194.8095.50-1688-0.15%
2024/10/142121.0000.00121.0028170.24%
2024/10/0900.003122.00119.00-3838-0.36%
2024/10/073108.5000.00116.5038300.36%
2024/09/231163.5000.00158.0017940.13%
2024/09/1900.001178.50177.00-1785-0.13%
2024/09/1300.001176.50178.00-1779-0.13%
2024/09/1100.0030173.50185.00-30792-3.78%
2024/08/271220.0000.00220.0017850.13%
2024/08/2200.001222.00221.50-1798-0.13%
2024/08/211227.0000.00225.0018020.12%
2024/08/1300.001194.50189.00-1843-0.12%
2024/08/121204.000.5204.00198.000.58350.06%
2024/08/0900.004198.50203.50-4824-0.49%
2024/08/0800.001187.00187.00-1794-0.13%
2024/08/0100.001171.50175.50-1732-0.14%
2024/07/312157.001161.00161.0017270.14%
2024/07/292146.0000.00141.5027080.28%
2024/07/2300.001154.50160.00-1685-0.15%
2024/07/1913195.422180.75182.00116501.69%
2024/07/1821196.122196.75196.50196113.11%
2024/07/173179.0000.00191.0035890.51%
2024/07/1212.5161.5700.00162.0012.55442.30%
2024/07/1100.004149.00149.00-4531-0.75%
2024/06/174106.7500.00108.0043531.13%
2024/05/2800.00399.00100.00-3312-0.96%
2024/05/2700.001100.00100.00-1307-0.33%
2024/05/2100.00287.8093.00-2250-0.80%
2024/05/20285.80185.0086.3012380.42%
2024/05/1000.000.476.2076.50-0.4258-0.15%
2024/04/30472.1400.0071.3042581.55%
2024/04/1700.00466.7067.00-4253-1.58%
2024/03/2800.00668.5069.50-6244-2.45%
2024/03/2600.00370.6069.30-3241-1.24%
2024/03/25469.8000.0069.8042371.68%
2024/03/2200.00163.2064.30-1230-0.43%
2024/03/18259.6000.0059.6022260.88%
2024/03/12262.1000.0059.9022220.90%
2024/03/0400.00760.2060.20-7193-3.62%
2024/03/01254.6000.0054.8021831.09%
2024/02/26152.0000.0052.1011810.55%
2024/02/15255.5000.0055.5021771.12%
2024/02/01742.8700.0043.8571534.57%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音